NOC2L
protein-codingNOC2 like nucleolar associated transcriptional repressor, the group of Armadillo like helical domain containing|Protein phosphatase 1 regulatory subunits
Gene summary
Histone modification by histone acetyltransferases (HAT) and histone deacetylases (HDAC) can control major aspects of transcriptional regulation. NOC2L represents a novel HDAC-independent inhibitor of histone acetyltransferase (INHAT) (Hublitz et al., 2005 [PubMed 16322561]).[supplied by OMIM, Mar 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~15.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NOC2L variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015658.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 6 | 5 | 13 | ||
| missense | 157 | 11 | 168 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 0 | 0 | 163 | 17 | 5 | 185 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056473.3 | 19 | MANE Select | |
| Ensembl | ENSP00000317992.6 | 19 | MANE Select | |
| Ensembl | ENSP00000540784.1 | 19 | Standard | |
| Ensembl | ENSP00000540784.1 | 19 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| noc2l | Danio rerio | Structure: anatomical system Quality: quality abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gene expression (Transcription)
- Generic Transcription Pathway
- RNA Polymerase II Transcription
- Validated transcriptional targets of TAp63 isoforms
- Regulation of TP53 Activity through Phosphorylation
Biological Process
- negative regulation of transcription by RNA polymerase II
- negative regulation of B cell apoptotic process
- apoptotic process
- chromatin assembly
- cellular response to UV
Molecular Function
- chromatin binding
- transcription corepressor activity
- RNA binding
- protein binding
- nucleosome binding
Cellular Component
- nucleus
- nucleoplasm
- nucleolus
- cytosol
- Noc1p-Noc2p complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000327044
- Coding exons
- 19
- Length
- 15106
- Individuals with no LoFs
- 125546
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 201
- Defined
- 125747
- p
- 0.000800
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.90 | 577 | 462 | 1.25 | 0.0000293 | 4856 |
| Missense (PolyPhen) | 140 | 135.62 | 1.0323 | 1490 | ||
| Synonymous | -6.71 | 320 | 199 | 1.60 | 0.0000137 | 1471 |
| Loss of Function | -0.174 | 43 | 41.8 | 1.03 | 0.00000215 | 447 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00068 | 0.00068 | rare |
| Latino/Admixed American | 0.00043 | 0.00043 | rare |
| Ashkenazi Jewish | 0.0043 | 0.0043 | notable |
| East Asian | 0.00093 | 0.00092 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00083 | 0.00080 | rare |
| South Asian | 0.00050 | 0.00049 | rare |
| Other | 0.0013 | 0.0013 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Acts as an inhibitor of histone acetyltransferase activity; prevents acetylation of all core histones by the EP300/p300 histone acetyltransferase at p53/TP53-regulated target promoters in a histone deacetylases (HDAC)-independent manner. Acts as a transcription corepressor of p53/TP53- and TP63-mediated transactivation of the p21/CDKN1A promoter. Involved in the regulation of p53/TP53-dependent apoptosis. Associates together with TP63 isoform TA*-gamma to the p21/CDKN1A promoter. {ECO:0000269|PubMed:16322561, ECO:0000269|PubMed:20123734, ECO:0000269|PubMed:20959462}.;
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- LoFtool
- 0.887
- RVIS EVS
- 0.04
- RVIS percentile EVS
- 56.27
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.946
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |